200 related articles for article (PubMed ID: 30611016)
1. Generation of an induced pluripotent stem cell cohort suitable to investigate sporadic Alzheimer's Disease.
Schöndorf DC; Elschami M; Schieck M; Ercan-Herbst E; Weber C; Riesinger Y; Kalman S; Steinemann D; Ehrnhoefer DE
Stem Cell Res; 2019 Jan; 34():101351. PubMed ID: 30611016
[TBL] [Abstract][Full Text] [Related]
2. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
3. Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene.
Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
Stem Cell Res; 2019 Jan; 34():101381. PubMed ID: 30677723
[TBL] [Abstract][Full Text] [Related]
4. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
[TBL] [Abstract][Full Text] [Related]
5. Modelling Sporadic Alzheimer's Disease Using Induced Pluripotent Stem Cells.
Rowland HA; Hooper NM; Kellett KAB
Neurochem Res; 2018 Dec; 43(12):2179-2198. PubMed ID: 30387070
[TBL] [Abstract][Full Text] [Related]
6. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
Machairaki V
Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
[TBL] [Abstract][Full Text] [Related]
7. Generation of induced pluripotent stem cell line (ZZUi0013-A) from a 65-year-old patient with a novel MEOX2 gene mutation in Alzheimer's disease.
Wang Y; Sun H; Yang J; Shi C; Liu Y; Xu Y; Zhang J
Stem Cell Res; 2019 Jan; 34():101366. PubMed ID: 30616143
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons.
Nieweg K; Andreyeva A; van Stegen B; Tanriöver G; Gottmann K
Cell Death Dis; 2015 Apr; 6(4):e1709. PubMed ID: 25837485
[TBL] [Abstract][Full Text] [Related]
9. Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene.
Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
Stem Cell Res; 2019 May; 37():101438. PubMed ID: 31004935
[TBL] [Abstract][Full Text] [Related]
10. Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer's Disease.
Foveau B; Correia AS; Hébert SS; Rainone S; Potvin O; Kergoat MJ; Belleville S; Duchesne S; LeBlanc AC;
J Alzheimers Dis; 2019; 67(3):893-910. PubMed ID: 30689579
[TBL] [Abstract][Full Text] [Related]
11. Generation of a human induced pluripotent stem cell line from a patient with a rare A673T variant in amyloid precursor protein gene that reduces the risk for Alzheimer's disease.
Lehtonen Š; Höytyläinen I; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Oksanen M; Koistinaho J
Stem Cell Res; 2018 Jul; 30():96-99. PubMed ID: 29807259
[TBL] [Abstract][Full Text] [Related]
12. Increased susceptibility to Aβ toxicity in neuronal cultures derived from familial Alzheimer's disease (PSEN1-A246E) induced pluripotent stem cells.
Armijo E; Gonzalez C; Shahnawaz M; Flores A; Davis B; Soto C
Neurosci Lett; 2017 Feb; 639():74-81. PubMed ID: 28034781
[TBL] [Abstract][Full Text] [Related]
13. Generation of induced pluripotent stem cell line (IPTi001-A) from a 62-year old sporadic Alzheimer's disease patient with APOE3 (ε3/ε3) genotype.
Zhang L; Xu M; Liu G; Wu R; Meng S; Xiahou K; Jiang N; Zhang Y; Zhou W
Stem Cell Res; 2019 Dec; 41():101589. PubMed ID: 31689594
[TBL] [Abstract][Full Text] [Related]
14. Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.
Mungenast AE; Siegert S; Tsai LH
Mol Cell Neurosci; 2016 Jun; 73():13-31. PubMed ID: 26657644
[TBL] [Abstract][Full Text] [Related]
15. Establishment of induced pluripotent stem cells IRMBi005-A from a patient with sporadic Alzheimer's disease.
Provost CC; Auboyer L; Rovelet-Lecrux A; Monzo C; Schob E; Lehmann S; Wallon D; Crozet C
Stem Cell Res; 2023 Oct; 72():103216. PubMed ID: 37783001
[TBL] [Abstract][Full Text] [Related]
16. Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults.
Vlahos K; Sourris K; Mayberry R; McDonald P; Bruveris FF; Schiesser JV; Bozaoglu K; Lockhart PJ; Stanley EG; Elefanty AG
Stem Cell Res; 2019 Jan; 34():101380. PubMed ID: 30605840
[TBL] [Abstract][Full Text] [Related]
17. N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons.
Chang CY; Chen SM; Lu HE; Lai SM; Lai PS; Shen PW; Chen PY; Shen CI; Harn HJ; Lin SZ; Hwang SM; Su HL
Sci Rep; 2015 Mar; 5():8744. PubMed ID: 25735452
[TBL] [Abstract][Full Text] [Related]
18. Early pathogenic event of Alzheimer's disease documented in iPSCs from patients with PSEN1 mutations.
Yang J; Zhao H; Ma Y; Shi G; Song J; Tang Y; Li S; Li T; Liu N; Tang F; Gu J; Zhang L; Zhang Z; Zhang X; Jin Y; Le W
Oncotarget; 2017 Jan; 8(5):7900-7913. PubMed ID: 27926491
[TBL] [Abstract][Full Text] [Related]
19. Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases.
Tcw J
Neurosci Lett; 2019 Apr; 699():31-40. PubMed ID: 30685408
[TBL] [Abstract][Full Text] [Related]
20. Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes.
Raja WK; Mungenast AE; Lin YT; Ko T; Abdurrob F; Seo J; Tsai LH
PLoS One; 2016; 11(9):e0161969. PubMed ID: 27622770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
